Growth-promoting effects of substance P on endothelial cells in vitro: Synergism with calcitonin gene-related peptide, insulin, and plasma factors

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The purpose of this study was to determine the effects of the vasoactive perivascular neuropeptide substance P (SP) on the growth and function of vascular endothelial cells in serum-free culture conditions with cells quiescent in the G0-G1 phase of the cell cycle and to characterize the response. In addition, interactions between SP and other growth factors and neuropeptides including insulin, platelet factors, neurokinin A, neurokinin B, and calcitonin gene-related peptide (CGRP) were studied on endothelial cell growth and compared. Growth effects were determined by stimulation of tritiated thymidine incorporation into DNA and cell proliferation. SP exhibited differential effects on cell growth that were a function of concentration, incubation time, interaction with other growth factors, and cell culture conditions. DNA synthesis in response to SP showed a bell- shaped distribution with a maximal effect that was 10.5-fold over control at 500 μg/mL of SP after 48 hours of incubation. The effect showed marked synergism with insulin (10 μg/mL) and with CGRP (0.01 to 10 μg/mL), which is colocalized with SP in vivo. Insulin and CGRP alone had no significant effect on endothelial cell growth. Furthermore, no synergism was observed between SP and platelet-derived growth factor or platelet-derived endothelial cell growth factor. Endothelial cell proliferation increased in response to SP to 2.6-fold over control at 48 hours, was maximal at 10 μg/mL SP, and also demonstrated synergism with insulin (10 μg/mL). Our studies indicate that neuropeptides play a significant role in regulating endothelial cell growth and proliferation. The demonstrated synergism between SP and other known growth factors and neuropeptides implies that synergism between differing signal transduction pathways may be significant in the total observed response. These findings suggest that SP may have an important role in the normal and pathophysiological states of the vasculature.

Original languageEnglish (US)
Pages (from-to)1113-1120
Number of pages8
JournalCirculation Research
Volume75
Issue number6
StatePublished - Dec 1994

Fingerprint

Calcitonin Gene-Related Peptide
Substance P
Endothelial Cells
Insulin
Growth
Neuropeptides
Intercellular Signaling Peptides and Proteins
Cell Proliferation
In Vitro Techniques
Neurokinin B
Thymidine Phosphorylase
Neurokinin A
Cell Cycle Resting Phase
DNA
Platelet-Derived Growth Factor
G1 Phase
Thymidine
Signal Transduction
Cell Cycle
Blood Platelets

Keywords

  • cell growth
  • endothelial cell
  • neuropeptides
  • substance P
  • tachykinins

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

@article{8729c89daa0d4f3db62ca999dc7b4c71,
title = "Growth-promoting effects of substance P on endothelial cells in vitro: Synergism with calcitonin gene-related peptide, insulin, and plasma factors",
abstract = "The purpose of this study was to determine the effects of the vasoactive perivascular neuropeptide substance P (SP) on the growth and function of vascular endothelial cells in serum-free culture conditions with cells quiescent in the G0-G1 phase of the cell cycle and to characterize the response. In addition, interactions between SP and other growth factors and neuropeptides including insulin, platelet factors, neurokinin A, neurokinin B, and calcitonin gene-related peptide (CGRP) were studied on endothelial cell growth and compared. Growth effects were determined by stimulation of tritiated thymidine incorporation into DNA and cell proliferation. SP exhibited differential effects on cell growth that were a function of concentration, incubation time, interaction with other growth factors, and cell culture conditions. DNA synthesis in response to SP showed a bell- shaped distribution with a maximal effect that was 10.5-fold over control at 500 μg/mL of SP after 48 hours of incubation. The effect showed marked synergism with insulin (10 μg/mL) and with CGRP (0.01 to 10 μg/mL), which is colocalized with SP in vivo. Insulin and CGRP alone had no significant effect on endothelial cell growth. Furthermore, no synergism was observed between SP and platelet-derived growth factor or platelet-derived endothelial cell growth factor. Endothelial cell proliferation increased in response to SP to 2.6-fold over control at 48 hours, was maximal at 10 μg/mL SP, and also demonstrated synergism with insulin (10 μg/mL). Our studies indicate that neuropeptides play a significant role in regulating endothelial cell growth and proliferation. The demonstrated synergism between SP and other known growth factors and neuropeptides implies that synergism between differing signal transduction pathways may be significant in the total observed response. These findings suggest that SP may have an important role in the normal and pathophysiological states of the vasculature.",
keywords = "cell growth, endothelial cell, neuropeptides, substance P, tachykinins",
author = "Villablanca, {Amparo C} and Murphy, {Christopher J} and Reid, {Ted W.}",
year = "1994",
month = "12",
language = "English (US)",
volume = "75",
pages = "1113--1120",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Growth-promoting effects of substance P on endothelial cells in vitro

T2 - Synergism with calcitonin gene-related peptide, insulin, and plasma factors

AU - Villablanca, Amparo C

AU - Murphy, Christopher J

AU - Reid, Ted W.

PY - 1994/12

Y1 - 1994/12

N2 - The purpose of this study was to determine the effects of the vasoactive perivascular neuropeptide substance P (SP) on the growth and function of vascular endothelial cells in serum-free culture conditions with cells quiescent in the G0-G1 phase of the cell cycle and to characterize the response. In addition, interactions between SP and other growth factors and neuropeptides including insulin, platelet factors, neurokinin A, neurokinin B, and calcitonin gene-related peptide (CGRP) were studied on endothelial cell growth and compared. Growth effects were determined by stimulation of tritiated thymidine incorporation into DNA and cell proliferation. SP exhibited differential effects on cell growth that were a function of concentration, incubation time, interaction with other growth factors, and cell culture conditions. DNA synthesis in response to SP showed a bell- shaped distribution with a maximal effect that was 10.5-fold over control at 500 μg/mL of SP after 48 hours of incubation. The effect showed marked synergism with insulin (10 μg/mL) and with CGRP (0.01 to 10 μg/mL), which is colocalized with SP in vivo. Insulin and CGRP alone had no significant effect on endothelial cell growth. Furthermore, no synergism was observed between SP and platelet-derived growth factor or platelet-derived endothelial cell growth factor. Endothelial cell proliferation increased in response to SP to 2.6-fold over control at 48 hours, was maximal at 10 μg/mL SP, and also demonstrated synergism with insulin (10 μg/mL). Our studies indicate that neuropeptides play a significant role in regulating endothelial cell growth and proliferation. The demonstrated synergism between SP and other known growth factors and neuropeptides implies that synergism between differing signal transduction pathways may be significant in the total observed response. These findings suggest that SP may have an important role in the normal and pathophysiological states of the vasculature.

AB - The purpose of this study was to determine the effects of the vasoactive perivascular neuropeptide substance P (SP) on the growth and function of vascular endothelial cells in serum-free culture conditions with cells quiescent in the G0-G1 phase of the cell cycle and to characterize the response. In addition, interactions between SP and other growth factors and neuropeptides including insulin, platelet factors, neurokinin A, neurokinin B, and calcitonin gene-related peptide (CGRP) were studied on endothelial cell growth and compared. Growth effects were determined by stimulation of tritiated thymidine incorporation into DNA and cell proliferation. SP exhibited differential effects on cell growth that were a function of concentration, incubation time, interaction with other growth factors, and cell culture conditions. DNA synthesis in response to SP showed a bell- shaped distribution with a maximal effect that was 10.5-fold over control at 500 μg/mL of SP after 48 hours of incubation. The effect showed marked synergism with insulin (10 μg/mL) and with CGRP (0.01 to 10 μg/mL), which is colocalized with SP in vivo. Insulin and CGRP alone had no significant effect on endothelial cell growth. Furthermore, no synergism was observed between SP and platelet-derived growth factor or platelet-derived endothelial cell growth factor. Endothelial cell proliferation increased in response to SP to 2.6-fold over control at 48 hours, was maximal at 10 μg/mL SP, and also demonstrated synergism with insulin (10 μg/mL). Our studies indicate that neuropeptides play a significant role in regulating endothelial cell growth and proliferation. The demonstrated synergism between SP and other known growth factors and neuropeptides implies that synergism between differing signal transduction pathways may be significant in the total observed response. These findings suggest that SP may have an important role in the normal and pathophysiological states of the vasculature.

KW - cell growth

KW - endothelial cell

KW - neuropeptides

KW - substance P

KW - tachykinins

UR - http://www.scopus.com/inward/record.url?scp=0028033645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028033645&partnerID=8YFLogxK

M3 - Article

C2 - 7525104

AN - SCOPUS:0028033645

VL - 75

SP - 1113

EP - 1120

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -